167 related articles for article (PubMed ID: 31799600)
1. LARMD: integration of bioinformatic resources to profile ligand-driven protein dynamics with a case on the activation of estrogen receptor.
Yang JF; Wang F; Chen YZ; Hao GF; Yang GF
Brief Bioinform; 2020 Dec; 21(6):2206-2218. PubMed ID: 31799600
[TBL] [Abstract][Full Text] [Related]
2. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
Shen J; Li W; Liu G; Tang Y; Jiang H
J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
[TBL] [Abstract][Full Text] [Related]
3. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
[TBL] [Abstract][Full Text] [Related]
4. HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
Mei LC; Wang YL; Wu FX; Wang F; Hao GF; Yang GF
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406224
[TBL] [Abstract][Full Text] [Related]
5. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
6. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
[TBL] [Abstract][Full Text] [Related]
8. Aliphatic substitution of o-carboranyl phenols enhances estrogen receptor beta selectivity.
Ohta K; Ogawa T; Kaise A; Oda A; Endo Y
Chem Pharm Bull (Tokyo); 2014; 62(4):386-91. PubMed ID: 24695349
[TBL] [Abstract][Full Text] [Related]
9. A Computational-Based Approach to Identify Estrogen Receptor
Coriano CG; Liu F; Sievers CK; Liang M; Wang Y; Lim Y; Yu M; Xu W
Mol Pharmacol; 2018 Mar; 93(3):197-207. PubMed ID: 29295894
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands.
Ohta K; Ogawa T; Oda A; Kaise A; Endo Y
Bioorg Med Chem Lett; 2015 Oct; 25(19):4174-8. PubMed ID: 26298498
[TBL] [Abstract][Full Text] [Related]
11. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
Burendahl S; Danciulescu C; Nilsson L
Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.
Paulmurugan R; Tamrazi A; Massoud TF; Katzenellenbogen JA; Gambhir SS
Mol Endocrinol; 2011 Dec; 25(12):2029-40. PubMed ID: 22052998
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal estrogen receptor isoform-selective biphenyls.
Bhatnagar S; Soni A; Kaushik S; Rikhi M; Santhoshkumar TR; Jayaram B
Chem Biol Drug Des; 2018 Feb; 91(2):620-630. PubMed ID: 29052968
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.
Charn TH; Liu ET; Chang EC; Lee YK; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2010 Jan; 24(1):47-59. PubMed ID: 19897598
[TBL] [Abstract][Full Text] [Related]
15. Ligand selectivity of estrogen receptors by a molecular dynamics study.
Hu G; Wang J
Eur J Med Chem; 2014 Mar; 74():726-35. PubMed ID: 23694906
[TBL] [Abstract][Full Text] [Related]
16. Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange.
Dai SY; Burris TP; Dodge JA; Montrose-Rafizadeh C; Wang Y; Pascal BD; Chalmers MJ; Griffin PR
Biochemistry; 2009 Oct; 48(40):9668-76. PubMed ID: 19739677
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
[TBL] [Abstract][Full Text] [Related]
19. Selectively targeting estrogen receptors for cancer treatment.
Shanle EK; Xu W
Adv Drug Deliv Rev; 2010 Oct; 62(13):1265-76. PubMed ID: 20708050
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
